NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY
NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY
批准号:
6639571
负责人:
EUGENE M JOHNSON
金额:
$25.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-10 至 2004-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract): By chance, the applicant has
produced a truncated mutant of Bax, which turned out to be a potent suppressor
of neuronal apoptosis. Much of his application will focus on this finding. He
will begin by investigating the mechanism by which sympathetic neurons mature
to a non-NGF dependent state; he proposes 3 hypotheses to test here: (a) loss
of dependence is due to an alteration in pattern of expression of members of
the BCL-2 family; (b) a protein is expressed that sequesters BAX in cytoplasm,
thus preventing its translocation to the mitochondria; or (c) there is an
age-dependent post-translational modification of BAX. The second specific aim
is to extend structure-function analysis of truncation mutants of Bax as
suppressors of neuronal apoptosis. He will also determine if truncation mutants
of other pro-apoptotic members of the BCL-2 family are anti-apoptotic. His
third specific aim is see if truncated BAX also protects other cell types,
including macroglia, fibroblasts, and lymphocytes, against apoptosis. Specific
aim 4 will test whether truncated Bax blocks translocation of BAX to the
mitochondria, or the loss of cytochrome c from the mitochondria. Finally, with
an experienced collaborator, the investigator will generate tBAX transgenics.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Alternating metabolic pathways in NGF-deprived sympathetic neurons affect caspase-independent death.
DOI:
10.1083/jcb.200302109
发表时间:
2003-07-21
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Chang LK, Schmidt RE, Johnson EM Jr]
通讯作者:
Johnson EM Jr
Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.
混合谱系激酶抑制剂需要激活 Trk 受体以维持长期神经元营养和存活。
DOI:
10.1124/jpet.104.077800
发表时间:
2005
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
[Wang,LeoH, Paden,AndrewJ, JohnsonJr,EugeneM]
通讯作者:
JohnsonJr,EugeneM
DOI:
10.1083/jcb.200112130
发表时间:
2002-05-27
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Chang LK, Johnson EM Jr]
通讯作者:
Johnson EM Jr
Apoptosis of ESNLCs
-
批准号:6565293
-
项目类别:
-
资助金额:$17.53万
-
财政年份:2001
-
负责人:EUGENE M JOHNSON
-
依托单位:
Apoptosis of ESNLCs
-
批准号:6410680
-
项目类别:
-
资助金额:$17.53万
-
财政年份:2000
-
负责人:EUGENE M JOHNSON
-
依托单位:
NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY
-
批准号:2839967
-
项目类别:
-
资助金额:$24.52万
-
财政年份:1999
-
负责人:EUGENE M JOHNSON
-
依托单位:
ES CELL TRANSPLANTATION AFTER SPINAL CORD INJURY
-
批准号:6625482
-
项目类别:
-
资助金额:$106.77万
-
财政年份:1999
-
负责人:EUGENE M JOHNSON
-
依托单位:
NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY
-
批准号:6187941
-
项目类别:
-
资助金额:$24.03万
-
财政年份:1999
-
负责人:EUGENE M JOHNSON
-
依托单位:
Apoptosis of ESNLCs
-
批准号:6326690
-
项目类别:
-
资助金额:$17.53万
-
财政年份:1999
-
负责人:EUGENE M JOHNSON
-
依托单位:
NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY
-
批准号:6394124
-
项目类别:
-
资助金额:$24.71万
-
财政年份:1999
-
负责人:EUGENE M JOHNSON
-
依托单位:
NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY
-
批准号:6540090
-
项目类别:
-
资助金额:$25.27万
-
财政年份:1999
-
负责人:EUGENE M JOHNSON
-
依托单位:
ES CELL TRANSPLANTATION AFTER SPINAL CORD INJURY
-
批准号:6696307
-
项目类别:
-
资助金额:$106.41万
-
财政年份:1999
-
负责人:EUGENE M JOHNSON
-
依托单位:
ES CELL TRANSPLANTATION AFTER SPINAL CORD INJURY
-
批准号:6477172
-
项目类别:
-
资助金额:$106.78万
-
财政年份:1999
-
负责人:EUGENE M JOHNSON
-
依托单位:
BIOLOGY AND PHARMACOLOGY OF THE GDNF HOMOLOG NEURTURIN
-
批准号:2390090
-
项目类别:
-
资助金额:$33.25万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
Biology & Pharmaclogy of the GDNF Family of Ligands
-
批准号:6785363
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
Biology & Pharmaclogy of the GDNF Family of Ligands
-
批准号:6383959
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
BIOLOGY AND PHARMACOLOGY OF THE GDNF HOMOLOG NEURTURIN
-
批准号:2055725
-
项目类别:
-
资助金额:$32.29万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
BIOLOGY AND PHARMACOLOGY OF THE GDNF HOMOLOG NEURTURIN
-
批准号:6168819
-
项目类别:
-
资助金额:$36.72万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
Biology & Pharmaclogy of the GDNF Family of Ligands
-
批准号:6615743
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
BIOLOGY AND PHARMACOLOGY OF THE GDNF HOMOLOG NEURTURIN
-
批准号:2899781
-
项目类别:
-
资助金额:$35.52万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
BIOLOGY AND PHARMACOLOGY OF THE GDNF HOMOLOG NEURTURIN
-
批准号:2683167
-
项目类别:
-
资助金额:$34.36万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
Biology & Pharmaclogy of the GDNF Family of Ligands
-
批准号:6532485
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
BIOLOGY AND PHARMACOLOGY OF THE GDNF HOMOLOG NEURTURIN
-
批准号:6440461
-
项目类别:
-
资助金额:$12.11万
-
财政年份:1996
-
负责人:EUGENE M JOHNSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: